Funder
Department of Education of Zhejiang Province
National Natural Science Foundation of China
Zhejiang Province Natural Science Foundation
Reference36 articles.
1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: Cancer J. Clin.,2021
2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N. Engl. J. Med.,2009
3. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?, Nature reviews;Recondo;Clin. Oncol.,2018
4. First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study;Douillard;Br. J. Cancer,2014
5. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors;Westover;Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol.,2018